Singapore: HSA Alert: One person admitted to ICU and another developed serious adverse reactions after consuming health products obtained overseas: AUSBEE AUSTRALIA® AUSBEE Herbal Powder Capsules and SHEN LOON SHE™ EDOLY CAPSULE (English Only)
The Health Sciences Authority (HSA) is alerting members of the public not to purchase or consume the following two health products. HSA has tested the products and found that they contain the following potent western medicinal ingredients which are prohibited in these products: 
- AUSBEE AUSTRALIA® AUSBEE Herbal Powder Capsules: contains dexamethasone, chloramphenicol, chlorpheniramine, ibuprofen and tetracycline 
- SHEN LOON SHE™ EDOLY CAPSULE (神農氏™ 益多利): contains dexamethasone and chlorpheniramine 

A woman in her 70s had been consuming ‘AUSBEE AUSTRALIA® AUSBEE Herbal Powder Capsules’ for about two years to relieve her back pain and for general well-being. The product was obtained from Malaysia through her friends. She underwent surgery due to a fracture and suffered complications arising from an adrenal crisis which caused a severe drop in her blood pressure. She was admitted to the ICU. Her condition was subsequently traced to the long-term consumption of dexamethasone, a potent steroid present in ‘AUSBEE AUSTRALIA® AUSBEE Herbal Powder Capsules’. In addition to the steroid, the product is adulterated with antibiotics, a painkiller and an anti-allergy drug which can cause serious adverse reactions and drug interactions. 

A man in his 60s had been taking ‘SHEN LOON SHE™ EDOLY CAPSULE’, which he obtained from Malaysia, to relieve his joint pain for almost a decade. He developed Cushing’s syndrome, a condition caused by long-term consumption of steroids. He had symptoms characteristic of this condition - skin thinning, large purplish bruises on the skin, high blood pressure and elevated blood glucose level. He is currently being treated for the condition. 

Please refer to the following website in HSA for details: 

In Hong Kong, the above products are not registered pharmaceutical products. 

Ends/Tuesday, May 15, 2018 
Issued at HKT 15:00